86 related articles for article (PubMed ID: 20303595)
1. Secretion of a fungal protease represents a complement evasion mechanism in cerebral aspergillosis.
Rambach G; Dum D; Mohsenipour I; Hagleitner M; Würzner R; Lass-Flörl C; Speth C
Mol Immunol; 2010 Apr; 47(7-8):1438-49. PubMed ID: 20303595
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of the local complement system in cerebral aspergillosis.
Rambach G; Hagleitner M; Mohsenipour I; Lass-Flörl C; Maier H; Würzner R; Dierich MP; Speth C
Microbes Infect; 2005 Oct; 7(13):1285-95. PubMed ID: 16027023
[TBL] [Abstract][Full Text] [Related]
3. Gliotoxin as putative virulence factor and immunotherapeutic target in a cell culture model of cerebral aspergillosis.
Speth C; Kupfahl C; Pfaller K; Hagleitner M; Deutinger M; Würzner R; Mohsenipour I; Lass-Flörl C; Rambach G
Mol Immunol; 2011 Sep; 48(15-16):2122-9. PubMed ID: 21803423
[TBL] [Abstract][Full Text] [Related]
4. Systematic identification of substrates for profiling of secreted proteases from Aspergillus species.
Schaal R; Kupfahl C; Buchheidt D; Neumaier M; Findeisen P
J Microbiol Methods; 2007 Nov; 71(2):93-100. PubMed ID: 17707935
[TBL] [Abstract][Full Text] [Related]
5. Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5.
Behnsen J; Lessing F; Schindler S; Wartenberg D; Jacobsen ID; Thoen M; Zipfel PF; Brakhage AA
Infect Immun; 2010 Aug; 78(8):3585-94. PubMed ID: 20498262
[TBL] [Abstract][Full Text] [Related]
6. Complement induction and complement evasion in patients with cerebral aspergillosis.
Rambach G; Maier H; Vago G; Mohsenipour I; Lass-Flörl C; Defant A; Würzner R; Dierich MP; Speth C
Microbes Infect; 2008; 10(14-15):1567-76. PubMed ID: 18977454
[TBL] [Abstract][Full Text] [Related]
7. Characterization and identification of proteases secreted by Aspergillus fumigatus using free flow electrophoresis and MS.
Neustadt M; Costina V; Kupfahl C; Buchheidt D; Eckerskorn C; Neumaier M; Findeisen P
Electrophoresis; 2009 Jun; 30(12):2142-50. PubMed ID: 19582717
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
[TBL] [Abstract][Full Text] [Related]
9. Expression and secretion of Aspergillus fumigatus proteases are regulated in response to different protein substrates.
Farnell E; Rousseau K; Thornton DJ; Bowyer P; Herrick SE
Fungal Biol; 2012 Sep; 116(9):1003-12. PubMed ID: 22954343
[TBL] [Abstract][Full Text] [Related]
10. Interference of Aspergillus fumigatus with the immune response.
Heinekamp T; Schmidt H; Lapp K; Pähtz V; Shopova I; Köster-Eiserfunke N; Krüger T; Kniemeyer O; Brakhage AA
Semin Immunopathol; 2015 Mar; 37(2):141-52. PubMed ID: 25404120
[TBL] [Abstract][Full Text] [Related]
11. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus.
Roilides E; Dimitriadou A; Kadiltsoglou I; Sein T; Karpouzas J; Pizzo PA; Walsh TJ
J Immunol; 1997 Jan; 158(1):322-9. PubMed ID: 8977206
[TBL] [Abstract][Full Text] [Related]
12. Phylogeny and immune evasion: a putative correlation for cerebral Pseudallescheria/Scedosporium infections.
Rainer J; Rambach G; Kaltseis J; Hagleitner M; Heiss S; Speth C
Mycoses; 2011 Oct; 54 Suppl 3():48-55. PubMed ID: 21995663
[TBL] [Abstract][Full Text] [Related]
13. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
14. Azole-resistant central nervous system aspergillosis.
van der Linden JW; Jansen RR; Bresters D; Visser CE; Geerlings SE; Kuijper EJ; Melchers WJ; Verweij PE
Clin Infect Dis; 2009 Apr; 48(8):1111-3. PubMed ID: 19272019
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia.
Choi JH; Brummer E; Kang YJ; Jones PP; Stevens DA
J Infect Dis; 2006 Apr; 193(7):1023-8. PubMed ID: 16518765
[TBL] [Abstract][Full Text] [Related]
16. Diffuse myelitis after treatment of cerebral aspergillosis in an immune competent patient.
Mollahoseini R; Nikoobakht M
Acta Med Iran; 2011; 49(6):402-6. PubMed ID: 21874647
[TBL] [Abstract][Full Text] [Related]
17. Update on the treatment of cerebral aspergillosis.
Schwartz S; Thiel E
Ann Hematol; 2004; 83 Suppl 1():S42-4. PubMed ID: 15124667
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal granuloma of the brain caused by Aspergillus fumigatus: a case report and review of the literature.
Turgut M; Ozsunar Y; Oncü S; Akyüz O; Ertuğrul MB; Tekin C; Gültekin B; Sakarya S
Surg Neurol; 2008 Feb; 69(2):169-74; discussion 174. PubMed ID: 17825367
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of complement by culture supernatants of Aspergillus fumigatus.
Washburn RG; Hammer CH; Bennett JE
J Infect Dis; 1986 Dec; 154(6):944-51. PubMed ID: 3537152
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4.
Braedel S; Radsak M; Einsele H; Latgé JP; Michan A; Loeffler J; Haddad Z; Grigoleit U; Schild H; Hebart H
Br J Haematol; 2004 May; 125(3):392-9. PubMed ID: 15086422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
